Drugs / Xueshuantong
last change May 2023 re-read 3 minutes ago

Xueshuantong

Developed for
ischemic stroke
Investigated by
Dongzhimen Hospital, Beijing · Tianjin University of Traditional Chinese Medicine

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04415164 Sep 2020 → Oct 2022 ischemic stroke Dongzhimen Hospital, Beijing Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Xueshuantong ClinicalTrials.gov intervention name — accepted as the source's own label NCT04415164 ↗